Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2024-12-13 00:00:00 ET · period of report 2024-12-11 · accession 0001127602-24-029385 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-13 | 2024-12-11 | DNA | SLOAN HARRY | Dir | J - Other | — | +235.8K | 260.6K | +950% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-12-11 | J | A | 235,780 | — | 260,597 | D | — | — | (F1) Shares received in a distribution from Eagle Equity Partners III LLC to its members. (F2) This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024. |